AI-generated summary
The authors randomized 40 patients with meibomian gland dysfunction to low-level light therapy or intense pulsed light over four weekly sessions. Both treatments were associated with lower dryness symptom scores, with a greater symptom improvement and tear meniscus height increase reported for low-level light therapy, and no adverse events were reported.
- Participants
- 40
- Who or what was studied
- Patients with meibomian gland dysfunction (40 eyes of 40 patients)
- Limits stated in the abstract
- The abstract describes preliminary results from a single small randomized study, and it does not report wavelengths or a long-term follow-up period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.